Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerous liver tissue

ABSTRACT: microRNA profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue 166 pairs of hepatocellular carcinoma and matched noncancerous liver tissues

SUBMITTER:

PROVIDER: S-DIXA-D-1102 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

microRNA profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerous liver tissue

Project description:microRNA profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue

2011-08-16 | GSE31384 | GEO

microRNA profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerous liver tissue

Project description:microRNA profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue 166 pairs of hepatocellular carcinoma and matched noncancerous liver tissues

2011-08-15 | E-GEOD-31384 | biostudies-arrayexpress

LncRNA profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerous liver tissue

Project description:LncRNA profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue, aimed to analyze the lncRNA expression proﬁle of hepatocellular carcinoma (HCC) and identify prognosis-related lncRNAs.

2023-06-25 | GSE72170 | GEO

Transcriptional profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerousliver tissue

Project description:Transcriptional profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue

2011-02-12 | GSE27150 | GEO

Transcriptional profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerousliver tissue

Project description:Transcriptional profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue 81 pairs of hepatocellular carcinoma and matched noncancerousliver tissues

2011-02-12 | E-GEOD-27150 | biostudies-arrayexpress

Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma.

Project description:BackgroundHepatocellular carcinoma (HCC) can lead to liver failure which renders to liver transplant. miRNAs might be detected as biomarkers in subclinical stage of several hepatobiliary disorders like HCC. Therefore, in the present study, alterations in miRNAs as biomarkers were detected in LT patients with HCC.MethodsFourteen tissue samples composed of 5 rejected and 9 non-rejected ones were used for studying the miRNAs expression pattern using LNA-array probe assay and the result was evaluated by in house SYBR Green Real-time PCR protocols on 30 other tissue samples composed of 10 rejected and 20 non-rejected ones for the selected miRNAs. All samples were collected from liver transplanted patients with HCC.ResultsThe study results revealed that in rejected patients compared to non-rejected ones, hsa-miR-3158-5p, -4449, -4511, and -4633-5p were up-regulated and hsa-miR-122-3p, -194-5p, 548as-3p, and -4284 were down-regulated. ROC curve analysis also confirmed that miR194-5p and -548as-3p in up-regulated and also, miR-3158-5p, -4449 in down-regulated microRNAs are significantly important molecules in rejection.ConclusionFinally, the tissue levels of specific miRNAs (especially hsa-miR-3158-5p, -4449, -194-5p and -548as-3p) significantly correlated with the development of HCC, which can be present as biomarkers after further completing studies.

| S-EPMC8199419 | biostudies-literature

microRNA profile of human nasopharyngeal tissues: nasopharyngeal carcinoma tissues vs. normal nasopharyngeal tissues

Project description:MicroRNAs are biomarkers of prognosis and survival for many types of cancer. We evaluated whether microRNAs can predict the survival and efficacy of concurrent chemotherapy in nasopharyngeal carcinoma (NPC) patients. We retrospectively analyzed microRNA expression in 312 paraffin-embedded NPC specimens and 18 normal nasopharyngeal tissues using microarray. We found Forty-one microRNAs are differentially expressed between NPC and normal tissues, and a five-microRNA signature can predict survival independent of stage. NPC patients with the low-risk microRNA signature have a favorable response to concurrent chemotherapy.

2012-07-01 | GSE32960 | GEO

MicroRNA expression profile in human hepatocellular carcinoma

Project description:MicroRNA expression profile in human hepatocellular carcinoma

| PRJNA477559 | ENA

hepatocellular carcinoma vs. corresponding noncancerous liver or normal liver

Project description: Not available

| S-DIXA-D-1138 | biostudies-other

MicroRNA Profile Predicts Recurrence of Hepatocellular Carcinoma in Milan Criteria Cases with Mild Liver Cirrhosis.

Project description: Not available

| S-DIXA-D-1060 | biostudies-other